Patents in Switzerland: an overview for foreign businesses

Switzerland is a priority filing destination for many foreign businesses, with a dense base of pharmaceutical, precision-engineering, medtech and luxury-goods companies, a strong licensing market and a long patent tradition. The legal substance of Swiss patent law will look familiar to anyone who knows the major systems, but two features catch foreign applicants out: a Swiss national patent is currently granted without any substantive check of whether the invention is actually new or inventive (a position that is changing under a reform taking effect on 1 January 2027), and Switzerland is not in the European Union, so EU-level instruments do not automatically reach it. This page frames how the routes fit together at a high level and points to detailed walkthroughs for the mechanics. It is general information rather than legal advice, and the wider context sits in our Switzerland jurisdiction overview.

What a patent protects in Switzerland

A Swiss patent protects an invention, broadly a technical solution to a technical problem. To be patentable, an invention must generally be new (not part of the state of the art made available to the public before the relevant date), involve an inventive step (it would not have been obvious to a skilled person), and be capable of industrial application. Certain things are excluded, and the treatment of software-related, biotech and medical-method inventions is technical and turns on the claim wording, so it is worth taking local advice early rather than assuming a foreign patent will translate directly. Protection is tied to what the claims of the granted patent define, so drafting determines what you actually own. A Swiss patent runs for a defined term measured from the filing date, subject to renewal (annuity) payments to keep it in force; confirm the exact term, any supplementary protection arrangements for products such as medicines, and the annuity schedule with the IPI or local counsel rather than treating them as fixed.

The principal routes to protection

This is the point to get right. The first route is a Swiss national patent granted by the IPI (the Swiss Federal Institute of Intellectual Property), a Swiss national office. The second is a European patent, examined and granted centrally by the European Patent Office (EPO) under the European Patent Convention; once granted and validated in Switzerland it takes effect there as if it were a national patent. Switzerland is a contracting state of the European Patent Convention, even though it is not an EU member, which is precisely why the EPO route is available. The IPI is not the EPO, and the EPO is not an EU body. There is also a forthcoming third pathway: from 1 January 2027 an applicant will be able to request an optional full examination of a Swiss national application (see below), producing a fully examined national patent rather than the search-only grant that exists today. Which route, or which combination, fits your commercial map is a genuinely fact-specific judgement, and we walk through the mechanics in our guide to filing a patent in Switzerland.

The national patent and the 2027 examination reform

Here is the feature that surprises applicants from most other systems. When the IPI examines a Swiss national application under the current law, it checks the formal and technical requirements, but it does not substantively examine whether the invention is novel or whether it involves an inventive step. A Swiss national patent is therefore currently granted without that validity check having been made by the office, and its novelty and inventive step are tested only if and when the patent is litigated, before the Federal Patent Court (the specialist Swiss court for patent disputes). In practical terms you can obtain a Swiss national right relatively cleanly today, but you should not read grant as a verdict on strength.

This is changing. Under the revised Swiss Patents Act, with changes due to take effect on 1 January 2027, the IPI will produce a prior-art (state-of-the-art) search report on national applications, and applicants will be able to request an optional full examination of all patentability requirements, including novelty and inventive step, yielding a fully examined Swiss national patent. The exact scope, fees and timing of the reform, and whether it applies to your filing, should be confirmed with the IPI or local counsel rather than treated as settled here. The European patent route is examined regardless: the EPO conducts full substantive examination of novelty and inventive step before grant, so a European patent covering Switzerland has been through that scrutiny. From 2027 an applicant who elects the optional Swiss national examination can also obtain an examined national right, so the EPO will no longer be the only route to a fully examined patent effective in Switzerland. This difference shapes strategy, due diligence and enforcement risk, and we explain it in detail in our guide to the Swiss national patent and substantive examination.

One territory: Switzerland and Liechtenstein

A structural point that foreign applicants frequently miss: Switzerland and Liechtenstein form a single unitary patent protection territory under a long-standing bilateral treaty. A Swiss patent, whether obtained nationally through the IPI or as a European patent validated in Switzerland, extends to both Switzerland and Liechtenstein as one territory; you cannot obtain a patent for only one of them, and no separate Liechtenstein filing or validation step is needed, since Liechtenstein is covered automatically. This single territory is administered by the IPI for both states. It is a separate concept from the EU instruments discussed below, so do not conflate this Switzerland-and-Liechtenstein territory with any EU-wide right.

Why the EU Unitary Patent does not cover Switzerland

Because Switzerland is neither an EU nor an EEA member, EU-level intellectual property instruments do not extend to it automatically, and patents are no exception. The EU Unitary Patent, introduced relatively recently, gives a single right covering participating EU member states and is enforced through the Unified Patent Court; it does not cover Switzerland, and a Unitary Patent alone will leave the Swiss (and Liechtenstein) market unprotected. To reach Switzerland you need either a Swiss national patent or a European patent that is validated for Switzerland. The same EU-exclusion logic applies more broadly across Swiss IP: an EU trade mark or a registered EU design does not cover Switzerland either, so foreign brands must secure a Swiss national right or designate Switzerland through the Madrid System for trade marks or the Hague System for designs. We set out how the EU Unitary Patent and the Unified Patent Court work, and why their reach stops at the EU's participating states, in our Unitary Patent and UPC overview.

Reaching Switzerland internationally

Many foreign applicants reach Switzerland through the Patent Cooperation Treaty rather than by filing directly: you file a single international application, then later enter the regional phase before the EPO (covering Switzerland) or the national phase. This defers country-specific costs and translation decisions. Regional and national-phase entry deadlines are strict and counted from your priority date, and you will usually rely on a Paris Convention priority claim from your first application to keep that date while filing later for Switzerland; treat the specific deadlines and the priority window as confirm-with-counsel details rather than fixed periods. Our overview of the PCT national and regional phase explains the international stage in general.

Maintenance fees and the Swissness point

A Swiss patent does not stay in force by itself. Renewal (annuity) fees fall due on a recurring basis to keep the patent alive for its term, and missing one can cause the patent to lapse. Official fees apply; confirm the current amount, the renewal schedule and any reinstatement options with the IPI or local counsel rather than relying on a fixed figure. One related commercial point worth flagging, distinct from patents but central to operating in Switzerland: the Swissness rules strictly control use of the words Swiss and Swiss made and the Swiss cross on products and in marketing, with criteria that must be met before such indications can be used. The tests differ by product category (foodstuffs, industrial goods, and a specific regime for watches), so confirm the current thresholds for your category with counsel. If your product trades on a Swiss origin claim, that is a separate compliance question to raise early.

This overview is general information about the Swiss patent system and is not legal advice. IPEnvoy is not a law firm and does not provide legal advice. Swiss patent law is detailed and changing, including the examination reform taking effect on 1 January 2027, and the deadlines, terms, fees and reform details described here in general terms should be confirmed against the IPI's official website and with a qualified local IP professional before you act. Where it helps, IPEnvoy can route you to vetted local counsel in Switzerland who can assess your specific position.